Concepedia

Lynn Jongen

LJ

Statistics

Publications

8

Citations

394

H-Index

8

Active since

2016

Affiliations

KU Leuven(Current)

Inserm

University of Milan

The Netherlands Cancer Institute

University of St.Gallen

Lynn Jongen is an author at KU Leuven specializing in oncology, medicine, and breast oncology.

ORCID

Publications per year

2016–2020

8

Publications

8

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Anabel Sanchez‐Spitman, Vincent O. Dezentjé, Jesse J. Swen et al. · Journal of Clinical Oncology · 2019 · 90 citations · Full text

, , +14

Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial

Patrick Neven, Lynn Jongen, Anneleen Lintermans et al. · Clinical Cancer Research · 2018 · 61 citations · Full text

, , +17

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Matteo Lambertini, Ana Catarina Pinto, Lieveke Ameye et al. · British Journal of Cancer · 2016 · 54 citations · Full text

, , +16

Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

Giuseppe Floris, François Richard, Anne‐Sophie Hamy et al. · JNCI Journal of the National Cancer Institute · 2020 · 48 citations · Full text

, , +13

Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer

Kathleen Van Asten, Laurence Slembrouck, Siel Olbrecht et al. · The Oncologist · 2018 · 44 citations · Full text

, , +16

1–5 of 8